Skip to content

Hard truths. Bold Insights. Real talk.

Radio Generation Kenya

Lenacapavir

Uganda approves twice-yearly HIV prevention injection
Global Affairs

Uganda approves twice-yearly HIV prevention injection

Lenacapavir, which received World Health Organization (WHO) endorsement in July 2025 and prequalification in October, delivers protection with just two shots per year. Uganda’s National Drug Authority described the approval as a “game changer” in a nation where roughly 5.4 per cent of adults live with HIV.

Twice-yearly HIV prevention shot gets green light in South Africa
Global Affairs

Twice-yearly HIV prevention shot gets green light in South Africa

The approval signals a new era for HIV prevention efforts in Africa’s most affected nation, where millions continue to live with the virus. Developed by US biopharmaceutical firm Gilead Sciences, lenacapavir was submitted for approval in March 2025 and has now been officially registered for use among HIV-negative adults and adolescents at high risk of infection.